Insmed Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business and Pipeline Update
BRIDGEWATER, N.J., Feb. 17, 2022 /PRNewswire/ — Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today reported financial results for the fourth quarter and full year ended December 31,…
Comments Off on Insmed Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business and Pipeline Update